We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$950M
(+7.4%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$45.6M |
| 2 |
Accenture
ACN
|
+$41.1M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.7M |
| 4 |
Hormel Foods
HRL
|
+$32.9M |
| 5 |
PACCAR
PCAR
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$61.7M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$23.5M |
| 3 |
ORB
ORBITAL SCIENCES CORP
ORB
|
+$21.2M |
| 4 |
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
|
+$21.1M |
| 5 |
Hope Bancorp
HOPE
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
901
DELISTED
Acceleron Pharma
XLRN
| $445K | ﹤0.01% |
11,717
| – | – |
|
|
CTCT
902
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $444K | ﹤0.01% |
11,625
| – | – |
|
903
Arista Networks
ANET
$215B
| $443K | ﹤0.01% |
100,704
+81,504
| +425% | +$338K |
|
|
BKEP
904
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $437K | ﹤0.01% |
56,350
| – | – |
|
|
SXE
905
DELISTED
Southcross Energy Partners, L.P.
SXE
| $437K | ﹤0.01% |
31,300
| – | – |
|
906
Bausch Health
BHC
$1.67B
| $436K | ﹤0.01% |
2,200
+229
| +12% | +$40.6K |
|
907
Sonoco
SON
$5.8B
| $435K | ﹤0.01% |
9,612
+3,242
| +51% | +$147K |
|
|
VSTO
908
DELISTED
Vista Outdoor Inc.
VSTO
| $435K | ﹤0.01% |
+10,200
| New | +$433K |
|
909
American Water Works
AWK
$26.3B
| $434K | ﹤0.01% |
8,033
+375
| +5% | +$20.4K |
|
910
Green Plains
GPRE
$1.15B
| $434K | ﹤0.01% |
15,220
+8,343
| +121% | +$208K |
|
|
SEM
911
DELISTED
Select Medical
SEM
| $433K | ﹤0.01% |
54,219
| – | – |
|
|
PMCS
912
DELISTED
P M C SIERRA INC
PMCS
| $431K | ﹤0.01% |
46,526
+42,166
| +967% | +$389K |
|
913
Copa Holdings
CPA
$5.65B
| $430K | ﹤0.01% |
4,271
-535
| -11% | -$58K |
|
914
OneSpan
OSPN
$562M
| $430K | ﹤0.01% |
19,988
+200
| +1% | +$4.74K |
|
|
PXD
915
DELISTED
Pioneer Natural Resource Co.
PXD
| $427K | ﹤0.01% |
2,615
| – | – |
|
916
Douglas Dynamics
PLOW
$1.04B
| $426K | ﹤0.01% |
18,681
| – | – |
|
|
SRDX
917
DELISTED
Surmodics
SRDX
| $426K | ﹤0.01% |
16,396
+6,690
| +69% | +$159K |
|
918
Booz Allen Hamilton
BAH
$8.59B
| $425K | ﹤0.01% |
14,730
| – | – |
|
919
Vanguard Small-Cap Growth ETF
VBK
$23.3B
| $425K | ﹤0.01% |
3,235
-129
| -4% | -$16.7K |
|
920
Restaurant Brands International
QSR
$25.8B
| $423K | ﹤0.01% |
11,038
| – | – |
|
921
Fresenius Medical Care
FMS
$13.4B
| $422K | ﹤0.01% |
10,197
-3,210
| -24% | -$124K |
|
922
Caleres
CAL
$420M
| $420K | ﹤0.01% |
12,829
+1,785
| +16% | +$54.4K |
|
923
Newmont
NEM
$98.5B
| $419K | ﹤0.01% |
19,385
-76
| -0.4% | -$1.78K |
|
|
SNBC
924
DELISTED
Sun Bancorp Inc
SNBC
| $416K | ﹤0.01% |
22,030
| – | – |
|
925
JB Hunt Transport Services
JBHT
$26.4B
| $414K | ﹤0.01% |
4,861
-533
| -10% | -$44.6K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.
- Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
- Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
- Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
- Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
- Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
- Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.
Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.